Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOROTHEO 2: doxofylline versus theophylline in asthma
ISRCTN22374987Phase 3Completed
- Sponsor
- Roberts Pharmaceutical
- Start
- Aug 1991
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Placebo, Doxofylline and Theophylline (3 arms). Primary endpoint: Percent change in FEV1 from baseline. Started Aug 1991; status: completed.
02
Drugs
doxofyllinetheophylline
03
Conditions
asthma
Beyond the preview
Go deeper on ISRCTN22374987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN22374987.